Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures
- PMID: 22752486
- PMCID: PMC3695701
- DOI: 10.1177/0883073812446485
Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures
Abstract
Tuberous sclerosis complex is a genetic disorder resulting in epilepsy and mental retardation. Vigabatrin has shown efficacy in the treatment of infantile spasms caused by tuberous sclerosis complex, but its effects on focal seizures caused by tuberous sclerosis complex have not been determined. We compared the efficacy of vigabatrin in patients with tuberous sclerosis complex-induced focal seizures and infantile spasms and assessed the mental outcomes in both groups. We retrospectively evaluated 31 children with tuberous sclerosis complex and epilepsy, who were treated with vigabatrin in a single tertiary center in Seoul, Korea. Vigabatrin treatment resulted in spasms cessation in 16 of 18 (88.9%) patients with infantile spasms, whereas 6 of 13 (46.2%) patients with focal seizures became seizure free. Initial response to vigabatrin had no effect on intellectual disability. Vigabatrin was highly effective in eliminating infantile spasms caused by tuberous sclerosis complex but was less effective in patients with focal seizures.
Conflict of interest statement
None of the authors has any conflict of interest to disclose.
Figures

Similar articles
-
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.Epilepsy Res. 2000 Feb;38(2-3):151-60. doi: 10.1016/s0920-1211(99)00082-0. Epilepsy Res. 2000. PMID: 10642043
-
Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.J Child Neurol. 2018 Jul;33(8):519-524. doi: 10.1177/0883073818768309. Epub 2018 Apr 24. J Child Neurol. 2018. PMID: 29687739
-
Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.J Child Neurol. 1999 Feb;14(2):71-4. doi: 10.1177/088307389901400201. J Child Neurol. 1999. PMID: 10073425 Review.
-
Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.Pediatr Neurol. 2015 Aug;53(2):141-5. doi: 10.1016/j.pediatrneurol.2015.04.012. Epub 2015 Apr 30. Pediatr Neurol. 2015. PMID: 26227562
-
Managing epilepsy in tuberous sclerosis complex.J Child Neurol. 2004 Sep;19(9):680-6. doi: 10.1177/08830738040190090801. J Child Neurol. 2004. PMID: 15563014 Review.
Cited by
-
Modeling epileptic spasms during infancy: Are we heading for the treatment yet?Pharmacol Ther. 2020 Aug;212:107578. doi: 10.1016/j.pharmthera.2020.107578. Epub 2020 May 15. Pharmacol Ther. 2020. PMID: 32417271 Free PMC article. Review.
-
The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.J Neurodev Disord. 2022 Feb 13;14(1):13. doi: 10.1186/s11689-022-09423-3. J Neurodev Disord. 2022. PMID: 35151277 Free PMC article.
-
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism.Neurotherapeutics. 2015 Jul;12(3):572-83. doi: 10.1007/s13311-015-0359-5. Neurotherapeutics. 2015. PMID: 25986747 Free PMC article. Review.
-
Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.Paediatr Drugs. 2020 Feb;22(1):73-84. doi: 10.1007/s40272-019-00376-0. Paediatr Drugs. 2020. PMID: 31912454 Review.
-
Potential roles of voltage-gated ion channel disruption in Tuberous Sclerosis Complex.Front Mol Neurosci. 2024 Aug 26;17:1404884. doi: 10.3389/fnmol.2024.1404884. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39253727 Free PMC article.
References
-
- Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–1356. - PubMed
-
- Thiele EA. Managing and understanding epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51 (Suppl 1):90–91. - PubMed
-
- Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372:657–668. - PubMed
-
- Jambaque I, Chiron C, Dumas C, et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res. 2000;38:151–160. - PubMed
-
- Angehagen M, Ben-Menachem E, Ronnback L, et al. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res. 2003;28:333–340. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical